T cell activation and polarization cytokines: supplementation levels and ratio design under the three-signal model

Author: Senior Product Manager of UA Views：4

This article focuses on the addition levels and ratio design of cytokines during the process of in vitro T cell activation, systematically elaborating the biological basis of the "dual-signal + cytokine" three-signal model, analyzing the synergistic mechanisms of three key components—anti-CD3 antibody, anti-CD28 antibody, and IL-2—in T cell activation, proliferation, and functional maintenance, and discussing the reference addition concentrations of each component and the value of their ratio logic in ensuring experimental reproducibility.

Recent Advances
Product Information

Recent Advances

Cytokines for T Cell Activation and Polarization: Added Concentrations and Ratio Design under the Three-Signal Model

Brief Introduction: This article focuses on the added concentrations and ratio design of cytokines during in vitro T cell activation, systematically elaborating the biological basis of the “two-signal + cytokine” three-signal model, analyzing the synergistic mechanisms of three key components—anti-CD3 antibody, anti-CD28 antibody, and IL-2—in T cell activation, proliferation, and functional maintenance, and discussing the reference added concentrations of each component and the value of their ratio logic in ensuring experimental reproducibility.

I. The Three-Signal Model of T Cell Activation and the Scientific Basis for Cytokine Added Concentrations.

Full activation and clonal expansion of T cells are driven jointly by three precisely coordinated signals rather than by a single signal alone. The first signal is the antigen-specific signal, which is transmitted intracellularly via the CD3 complex after the T cell receptor recognizes antigenic peptides and is commonly mimicked in experiments with anti-CD3 antibodies. The second signal is the costimulatory signal, provided by the binding of CD28 molecules on the T cell surface to B7 family molecules and supplied in experiments by anti-CD28 antibodies; it is the key permissive signal that determines whether T cells enter functional proliferation or progress to an anergic state. The third signal is the proliferation and survival signal, driven primarily by IL-2, and is the core element sustaining T cell growth and division. The strength, timing, and balance of the three signals jointly determine the number, phenotype, and function of the expanded T cells, and the added concentrations of cytokines are precisely the most direct controllable variables for regulating this balance.

From the perspective of experimental design, added concentrations are not better when higher. Excessive anti-CD3 signaling can lead to overactivation of T cells followed by activation-induced cell death; insufficient anti-CD28 signaling causes T cells to enter an anergic state; and deviation of IL-2 concentration from the optimal range may affect expansion efficiency or alter the balance between effector cells and regulatory cells. Therefore, the reference added concentrations of each component are optimized values determined after comprehensive consideration of activation efficiency, cell health status, and maintenance of functional phenotype.

II. Anti-CD3 Antibody: Immobilized Addition Scheme for the First Signal.

Anti-CD3 antibodies serve the function of mimicking the antigen recognition signal in T cell activation systems. In the standardized operating protocol, anti-CD3 antibody is diluted in PBS to a final concentration of 5 μg/mL, added at 1 mL per well to a 24-well plate for immobilization, incubated at 37°C for 2 hours or at 4°C overnight, after which the antibody solution is removed before cells are seeded. The key to this immobilization strategy lies in mimicking the multivalent antigen display on the membrane surface of antigen-presenting cells through solid-phase coating, thereby forming persistent stimulation of the TCR-CD3 complex and avoiding the signal attenuation that soluble antibodies may cause. In free-solution schemes, anti-CD3 antibodies can also be added to the culture medium in soluble form together with anti-CD28 antibodies, providing flexibility for different experimental needs. Whether the immobilized or free-solution method is used, the core role of anti-CD3 antibody is always to provide the initial specific signal for T cell activation.

III. Anti-CD28 Antibody: Costimulatory Added Concentration for the Second Signal.

Anti-CD28 antibodies provide the costimulatory signal essential for full T cell activation. In the standard protocol, anti-CD28 monoclonal antibody is added directly to complete culture medium containing cells at a final concentration of 5 μg/mL. This concentration setting matches the immobilized concentration of anti-CD3 antibody, ensuring that the costimulatory signal is delivered intracellularly in a timely and sufficient manner simultaneously with the initiation of TCR signaling. From a functional logic perspective, the strength of the anti-CD28 signal needs to be coordinated with the first signal: insufficient signaling will lead to T cell anergy, while excessive signaling may aggravate activation-induced cell death. The equal-concentration ratio design of anti-CD28 and anti-CD3 antibodies is precisely intended to strike a balance between full activation and cell health, enabling T cells to obtain potent activation signals while mitigating early apoptosis caused by excessive signaling, thereby achieving higher cell yields.

IV. IL-2: Proliferation-Driving Added Concentration for the Third Signal.

IL-2 performs the core function of driving clonal expansion and maintaining long-term survival of T cells in the system. In the reference protocol of the kit, the working concentration of IL-2 protein is set at 10 ng/mL. From a functional mechanism perspective, IL-2 binds to IL-2 receptors on the T cell surface, activates the JAK-STAT signaling pathway, promotes T cells to enter the cell cycle, and maintains the expression of anti-apoptotic proteins. Notably, IL-2 is not only a proliferation signal but also participates in the regulation of T cell subset polarization—under specific culture conditions, IL-2 signal strength can influence the balance between effector T cells and regulatory T cells. Therefore, the concentration setting of 10 ng/mL is an optimized value determined after comprehensive consideration of expansion efficiency, cell status, and maintenance of functional phenotype. In the kit specification design, the component contents of different specifications are adjusted proportionally and synchronously to ensure that the ratio relationships of the three signals remain consistent across different experimental scales, avoiding changes in activation conditions due to scale-up.

V. The Value of Standardized Ratio Design in Ensuring Experimental Reproducibility.

Traditional T cell activation methods rely on researchers titrating the concentrations of anti-CD3, anti-CD28 antibodies, and IL-2 themselves, a cumbersome process with variables that are difficult to control, directly affecting experimental reproducibility and cell quality. The activity of different antibody batches may vary, and inappropriate concentrations can easily lead to insufficient or excessive T cell activation followed by secondary apoptosis, affecting the reliability of subsequent functional experiments. The design philosophy of standardized kits is to free researchers from cumbersome condition optimization by directly providing a systematically optimized, ready-to-use protocol. Its core value is reflected at three levels: at the level of signal synergy, the anti-CD3, anti-CD28, and IL-2 components in the kit have undergone rigorous ratio optimization, which can effectively mitigate early apoptosis caused by excessive signaling while providing potent activation signals; at the operational level, ready-to-use kits eliminate the need to independently prepare and titrate the three key reagents, reducing human operational errors and batch-to-batch variation; at the level of data consistency, strict quality control ensures batch-to-batch consistency, providing a crucial foundation for data reproducibility in long-term research or multi-batch parallel experiments.

VI. Conclusion.

The added concentrations and ratio design of cytokines for T cell activation and polarization are core variables determining in vitro expansion efficiency, cell yield, and functional phenotype. From the immobilized coating of anti-CD3 antibody at 5 μg/mL and the costimulatory supplementation of anti-CD28 antibody at 5 μg/mL to the proliferation drive of IL-2 at 10 ng/mL, the three components form a precisely synergistic activation system within the framework of the three-signal model.

In response to the standardized requirements for in vitro T cell activation and expansion, Uia provides the Human T Cell Activation Kit/CellXViva Human T cell Activation Kit. This kit contains three key components—IL-2, anti-CD3 antibody, and anti-CD28 antibody—each systematically optimized in ratio, and is suitable for the activation and expansion of T cells derived from human PBMC, providing stable and reliable tool support for basic immunological research and cell therapy-related experiments.

This article is reviewed and published by the technical expert team of UA

Disclaimer: This article partially utilizes artificial intelligence assistance in its creation. If any content involves copyright or intellectual property issues, please let us know and we promise to verify and remove it as soon as possible.

Purchase recombinant protein, choose

UA protein focuses on providing various protein reagents, raw materials, and services required for drug research and development, cell therapy, gene therapy, and basic scientific research, including drug target proteins, immune checkpoint proteins, cytokines, tool enzymes, customized protein expression, and full-length transmembrane protein development. Nanjing Univ is committed to providing customers with high-quality products and professional services, and building a High-tech Biological Enterprise with International Competitiveness.

Buy antibodiesFind UA www.ua-bio.com | 15 years of protein development experience

Nanjing UNIV Biotechnology Co., Ltd. Email：order@ua-bio.com Phone：+86-25-56221161

more products

Product Information

The Last The Next